Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 1 , Pages 72-74 , January 2009

Optimizing outcomes at every stage of bladder cancer: Do we practice it?

References 

  1. Barghi MR, Rahmani MR, Hosseini-Moghaddam SM, et al. Immediate intravesical instillation of mitomycin C after transurethral resection of bladder tumor in patients with low-risk superficial transitional cell carcinoma of bladder. Urol J. 2006;3:220–224
  2. Solsona E, Iborra I, Ricos JV, et al. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup. J Urol. 1999;161:1120–1123
  3. Tolley DA, Parmar MK, Grigor KM, et al. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: A further report with 7 years of follow-up. J Urol. 1996;155:1233–1238
  4. Golijanin DJ, Kakiashvili D, Madeb RR, et al. Chemoprevention of bladder cancer. World J Urol. 2006;24:445–472
  5. Hall MC, Chang SS, Dalbagni G, et al. Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update. J Urol. 2007;178:2314–2330
  6. Herr HW, Donat SM, Dalbagni G. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?. J Urol. 2007;177:75–79Discussion 79
  7. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol. 2005;48:202–205Discussion 205–6
  8. Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349:859–866
  9. Pectasides D, Pectasides M, Nikolaou M. Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: Literature review. Eur Urol. 2005;48:60–67Discussion 67–8
  10. David KA, Milowsky MI, Ritchey J, et al. Low incidence of perioperative chemotherapy for Stage III bladder cancer 1998 to 2003: A report from the National Cancer Data Base. J Urol. 2007;178:451–454
  11. Stein JP, Penson DF, Cai J, et al. Radical cystectomy with extended lymphadenectomy: Evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol. 2007;177:876–881Discussion 881–2.
  12. Stein JP, Skinner DG. Radical cystectomy for invasive bladder cancer: Long-term results of a standard procedure. World J Urol. 2006;24:296–304
  13. Stein JP, Skinner DG. The role of lymphadenectomy in high-grade invasive bladder cancer. Urol Clin North Am. 2005;32:187–197
  14. Herr HW, Faulkner JR, Grossman HB, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004;22:2781–2789

PII: S1078-1439(08)00152-X

doi: 10.1016/j.urolonc.2008.06.005

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 1 , Pages 72-74 , January 2009

Article Tools